Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis. - Test2 - elhamkhani - TriplyDB

Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis.

Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis.

http://www.wikidata.org/entity/Q33435797

about

Delivery of host cell-directed therapeutics for intracellular pathogen clearance Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.Repurposing celecoxib as a topical antimicrobial agent.Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?Age of Bioterrorism: Are You Prepared? Review of Bioweapons and Their Clinical Presentation for Otolaryngologists.Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden.AR-13, a Celecoxib Derivative, Directly Kills Francisella In Vitro and Aids Clearance and Mouse Survival In Vivo.

P2860

Q27006858-DD6B03D8-4512-4259-BCF8-87CBCA9CE89C Q34323128-4FCAF78A-82FE-4543-91F7-CBFEBC61EEFE Q34509079-738F72D7-62DE-4A6C-997B-68CDFEA220C7 Q35895183-4051B8BB-1E5D-48DB-8EAF-0239FDC86D55 Q38193822-589FE7E5-50AD-4911-B5D8-DD89430FDDD1 Q38206493-2BDE5B87-8BD8-4059-8BA4-B5C34E320610 Q40608521-ADA3A885-5F5C-412D-B06F-C41D84F5F640 Q41684280-8586F7F8-F9E8-4087-8273-656713FB2A76

P2860

Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis.

http://www.wikidata.org/entity/Q33435797

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pharmacological exploitation o ...... gainst Francisella tularensis.

@ast

Pharmacological exploitation o ...... gainst Francisella tularensis.

@en

type

label

Pharmacological exploitation o ...... gainst Francisella tularensis.

@ast

Pharmacological exploitation o ...... gainst Francisella tularensis.

@en

prefLabel

Pharmacological exploitation o ...... gainst Francisella tularensis.

@ast

Pharmacological exploitation o ...... gainst Francisella tularensis.

@en

P1433

Q33435797-107B8588-8792-4459-9CF8-A851AC098788

P1476

Q33435797-D3E3D752-B46D-4298-92AF-181F013B944D

P2093

Q33435797-39D4A458-EC77-4C8D-AAC0-21C1FBFD0412

Q33435797-861B7E83-69A0-4A15-995F-11699C3011D6

Q33435797-CAC15178-2AE7-4A34-A727-8FCA9D026D49

Q33435797-E3793D18-8F17-49F7-9C4E-FE0643F03DB6

Q33435797-F4F2A137-125A-420F-A2A6-355C63471722

Q33435797-FE21A372-AE72-4EC8-8A37-1E9B2ECDC25E

P2860

Q33435797-07862CD5-53CC-4EAC-AEE5-4DFFB3613F62

Q33435797-21470BDF-8B35-4D97-9CE9-21D97B85F66C

Q33435797-376BE12C-5FD2-4FDD-9CFF-712C2D658031

Q33435797-39F2743C-F306-4CE9-9389-F651D79155E6

Q33435797-49D2427B-94B4-4162-9AB4-0A29F16BBC9B

Q33435797-5289C434-E686-459D-89D5-04D18C37F0B2

Q33435797-53D211BB-85E5-48E1-AFF4-36A6A7143C90

Q33435797-6DAD4124-BF7B-4106-8BFA-8E32A130D589

Q33435797-7614A3ED-78D2-44DA-AD34-FC74DA78E0AE

Q33435797-7713090D-9226-43E3-A3F3-01B8490A2E9C

P304

Q33435797-8366B831-C894-414B-B16A-E7096D6CE34E

P31

Q33435797-2D15DA06-F841-47DA-9C58-7A84DB405CCA

P356

Q33435797-015B24E4-457A-4937-B0CD-D2EF67594B6E

P407

Q33435797-9FAAF9F9-AFB8-4BE7-9ACF-2EA6A225B905

P433

Q33435797-F5C6FC9D-AB3C-4728-A926-C0C037A4BB27

P478

Q33435797-382D07D6-515E-42FA-B48B-6B91B41C0B99

P50

Q33435797-08C31356-6E1F-4BFD-8212-A65576F66E4B

P577

Q33435797-46929D3A-E8F1-4C9D-AB35-F685F89FE09E

P698

Q33435797-C509D6D5-7E30-4561-8FC0-753B177AF05E

P932

Q33435797-B03AF4F2-54C3-4267-BA36-B36EA458EC47

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacological exploitation o ...... gainst Francisella tularensis.

@en

P2093

Ching-Shih Chen

http://www.w3.org/2001/XMLSchema#string

Jian Yang

http://www.w3.org/2001/XMLSchema#string

John S Gunn

http://www.w3.org/2001/XMLSchema#string

Larry S Schlesinger

http://www.w3.org/2001/XMLSchema#string

Samuel K Kulp

http://www.w3.org/2001/XMLSchema#string

Shilpa Soni

http://www.w3.org/2001/XMLSchema#string

P2860

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy

Tularemia as a biological weapon: medical and public health management.

Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages.

Virulence determinants and protective antigens of Francisella tularensis.

AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence.

Tularaemia: bioterrorism defence renews interest in Francisella tularensis.

Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis.

Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape.

Francisella tularensis: unravelling the secrets of an intracellular pathogen.

P304

2998-3002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00048-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19398640

http://www.w3.org/2001/XMLSchema#string

P932

2704645

http://www.w3.org/2001/XMLSchema#string